Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1995
Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro
R J Motzer, L Schwartz, T M Law, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 10, 2000
Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression
A C Johnson, B A Murphy, C M Matelis, et al.
American Journal of Medical Genetics
|
March 15, 1993
Mosaic 5p tetrasomy
W S Stanley, C M Powell, G C Devine, et al.
Anesthesia and Analgesia
|
February 1, 1997
Cloricromene reduces myocardial infarct size in rabbits when administered during the early reperfusion period
D A Zvara, H J Galaska, V P Castellano, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 22, 2001
Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma
R J Motzer, A Rakhit, J A Thompson, et al.
Journal of Animal Science
|
February 1, 2007
Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse
M M Vick, A A Adams, B A Murphy, et al.
Animal Genetics
|
November 13, 2010
Morphological variation in the horse: defining complex traits of body size and shape
S A Brooks, S Makvandi-Nejad, E Chu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma
R J Motzer, B A Murphy, J Bacik, et al.
Biomedical Microdevices
|
December 18, 2008
Local drug delivery with a self-contained, programmable, microfluidic system
J Fiering, M J Mescher, E E Leary Swan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 24, 2009
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
C H Chung, J Aulino, N J Muldowney, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1995
Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro
R J Motzer, L Schwartz, T M Law, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 10, 2000
Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression
A C Johnson, B A Murphy, C M Matelis, et al.
American Journal of Medical Genetics
|
March 15, 1993
Mosaic 5p tetrasomy
W S Stanley, C M Powell, G C Devine, et al.
Anesthesia and Analgesia
|
February 1, 1997
Cloricromene reduces myocardial infarct size in rabbits when administered during the early reperfusion period
D A Zvara, H J Galaska, V P Castellano, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 22, 2001
Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma
R J Motzer, A Rakhit, J A Thompson, et al.
Journal of Animal Science
|
February 1, 2007
Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse
M M Vick, A A Adams, B A Murphy, et al.
Animal Genetics
|
November 13, 2010
Morphological variation in the horse: defining complex traits of body size and shape
S A Brooks, S Makvandi-Nejad, E Chu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma
R J Motzer, B A Murphy, J Bacik, et al.
Biomedical Microdevices
|
December 18, 2008
Local drug delivery with a self-contained, programmable, microfluidic system
J Fiering, M J Mescher, E E Leary Swan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 24, 2009
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
C H Chung, J Aulino, N J Muldowney, et al.
Page
of 6